MAIA Biotechnology, Inc.
MAIA · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $43,952 | $15,517 | $32,562 | $47,437 |
| - Cash | $9,601 | $7,151 | $10,951 | $10,574 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $34,351 | $8,366 | $21,611 | $36,862 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$23,255 | -$19,766 | -$15,762 | -$11,751 |
| % Margin | – | – | – | – |
| Net Income | -$23,255 | -$19,773 | -$15,769 | -$12,504 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.05 | -1.49 | -1.7 | -1.18 |
| % Growth | 29.5% | 12.4% | -44.1% | – |
| Operating Cash Flow | -$15,704 | -$13,071 | -$12,096 | -$4,123 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$15,704 | -$13,071 | -$12,096 | -$4,123 |